The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.
It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...